State Board of Administration of Florida Retirement System Decreases Stake in Steris Corp. (STE)
State Board of Administration of Florida Retirement System decreased its stake in Steris Corp. (NYSE:STE) by 87.8% during the second quarter, Holdings Channel reports. The firm owned 6,398 shares of the company’s stock after selling 46,116 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Steris Corp. were worth $440,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in the company. Virginia Retirement System acquired a new stake in Steris Corp. during the first quarter valued at $341,000. TIAA CREF Investment Management LLC raised its stake in Steris Corp. by 3.0% in the first quarter. TIAA CREF Investment Management LLC now owns 421,403 shares of the company’s stock valued at $29,941,000 after buying an additional 12,213 shares during the period. Teachers Advisors Inc. raised its stake in Steris Corp. by 2.1% in the first quarter. Teachers Advisors Inc. now owns 313,011 shares of the company’s stock valued at $22,239,000 after buying an additional 6,330 shares during the period. Prudential Financial Inc. raised its stake in Steris Corp. by 34.1% in the first quarter. Prudential Financial Inc. now owns 425,398 shares of the company’s stock valued at $30,225,000 after buying an additional 108,083 shares during the period. Finally, BlackRock Inc. raised its stake in Steris Corp. by 6.4% in the first quarter. BlackRock Inc. now owns 33,654 shares of the company’s stock valued at $2,392,000 after buying an additional 2,037 shares during the period. Hedge funds and other institutional investors own 91.58% of the company’s stock.
Shares of Steris Corp. (NYSE:STE) traded down 1.00% during midday trading on Friday, hitting $71.27. 609,322 shares of the company’s stock traded hands. The company has a 50 day moving average price of $71.44 and a 200 day moving average price of $70.40. The firm has a market capitalization of $6.14 billion, a price-to-earnings ratio of 40.94 and a beta of 1.14. Steris Corp. has a 1-year low of $61.38 and a 1-year high of $78.77.
Steris Corp. (NYSE:STE) last posted its earnings results on Tuesday, August 9th. The company reported $0.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.77 by $0.02. Steris Corp. had a net margin of 5.52% and a return on equity of 10.72%. The business had revenue of $638.40 million for the quarter, compared to analyst estimates of $639.04 million. During the same period last year, the business posted $0.62 EPS. Steris Corp.’s revenue was up 45.1% compared to the same quarter last year. Equities analysts anticipate that Steris Corp. will post $3.90 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 27th. Investors of record on Tuesday, August 30th were paid a $0.28 dividend. The ex-dividend date of this dividend was Friday, August 26th. This is a positive change from Steris Corp.’s previous quarterly dividend of $0.25. This represents a $1.12 dividend on an annualized basis and a yield of 1.57%. Steris Corp.’s dividend payout ratio (DPR) is presently 68.71%.
Separately, Zacks Investment Research lowered shares of Steris Corp. from a “buy” rating to a “sell” rating in a research note on Tuesday, July 19th.
In other Steris Corp. news, Director Richard Martin Steeves sold 204,778 shares of the firm’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $71.19, for a total value of $14,578,145.82. Following the sale, the director now directly owns 165,434 shares in the company, valued at approximately $11,777,246.46. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Adrian Vincent Coward sold 15,000 shares of the firm’s stock in a transaction on Wednesday, August 31st. The stock was sold at an average price of $69.00, for a total transaction of $1,035,000.00. The disclosure for this sale can be found here. 2.52% of the stock is currently owned by corporate insiders.
About Steris Corp.
STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Corp. (NYSE:STE).
Receive News & Ratings for Steris Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Corp. and related companies with MarketBeat.com's FREE daily email newsletter.